Advanced Medical Solutions Group plc

LSE AMS
£207.00 0.50 0.24%
Today share price
UK
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 71.25 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
43.74B
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
43.80B
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.72
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
221.34M
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
4.76 %

Upcoming events Advanced Medical Solutions Group plc

All events
No upcoming events scheduled

Stock chart Advanced Medical Solutions Group plc

Stock analysis Advanced Medical Solutions Group plc

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
1899.07 1899.07
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
179.15 181.65
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
696.66 696.66
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.94 0.94
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
9.57 9.57

Price change Advanced Medical Solutions Group plc per year

176.60£ 253.50£
Min Max

Summary analysis Advanced Medical Solutions Group plc

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Advanced Medical Solutions Group plc

Revenue and net income Advanced Medical Solutions Group plc

All parameters

About company Advanced Medical Solutions Group plc

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The company offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G brand names. It also provides wound care dressings, including silver alginates, alginates, and foams through its ActivHeal brand, as well as under white label. Advanced Medical Solutions Group plc was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Address:
Premier Park, Winsford, United Kingdom, CW7 3RT
Company name: Advanced Medical Solutions Group plc
Issuer ticker: AMS
ISIN: GB0004536594
Country: UK
Exchange: LSE
Currency: £
Sector: Healthcare
Site: https://www.admedsol.com